Article Details
Retrieved on: 2024-08-16 00:21:59
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
Guggenheim analyst Yatin Suneja lowered the firm's price target on Vigil Neuroscience to $16 from $17 and keeps a Buy rating on the shares.
Article found on: www.tipranks.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here